Trials / Unknown
UnknownNCT05350852
Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD+ B-ALL
To Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With MRD Positive Acute B-cell Leukemia
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, phase I study to assess the safety, efficacy and pharmacokinetics of ThisCART19A in patients with MRD+ B-ALL
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ThisCART19A | ThisCART19A is a new type CAR-T cells therapy for patients with acute B-cell leukemia |
Timeline
- Start date
- 2022-03-18
- Primary completion
- 2024-03-30
- Completion
- 2024-04-30
- First posted
- 2022-04-28
- Last updated
- 2022-04-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05350852. Inclusion in this directory is not an endorsement.